Radioimmunotherapy for non-Hodgkin's lymphoma: positioning, safety, and efficacy of 90Y-ibritumomab. 10 years of experience and follow-up
Keywords: لنفوم; Lymphoma; Non-Hodgkin; Radioimmunotherapy; Ibritumomab; Linfoma; No Hodgkin; Radioinmumoterapia; Ibritumomab;